Страна: Австралия
Език: английски
Източник: Department of Health (Therapeutic Goods Administration)
idarubicin hydrochloride, Quantity: 1 mg/mL
Pfizer (Perth) Pty Ltd
Injection, solution
Excipient Ingredients: glycerol; hydrochloric acid; water for injections
Intravenous, Intravenous Infusion
1 x 10 mL
(S1) This Schedule is intentionally blank
BRUNEI DARUSSALAM and MALAYSIA: Antimitotic and cytotoxic agent. Acute non-lymphocytic leukemia (ANLL) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients. Acute lymphocytic leukemia (ALL) as second line treatment in adults and children.
Visual Identification: Plastic vials containing a red-orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Listed (Export Only)
2023-03-02